MediKarma acquires Nanell, Hims & Hers to buy Eucalyptus
MediKarma has acquired Nanell from Niterra Co., Ltd., while Hims & Hers has announced an agreement to acquire Eucalyptus, signaling significant moves in the healthcare technology sector.
Novo Nordisk sues HIMS & HERS over generic drug patent
Novo Nordisk sues Hims & Hers for patent infringement over semaglutide compound product in US market, claiming misleading marketing and unsafe production.
Novo Nordisk stock surges after Hims & Hers withdraws weight loss pill
Novo Nordisk's stock rose up to 8.6% after Hims & Hers Health announced it would stop offering its semaglutide pill, following legal threats from the Danish company.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.